These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 22037979

  • 1. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S, Wada K, Nagatani K, Otani N, Osada H, Nawashiro H.
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract] [Full Text] [Related]

  • 2. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.
    Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
    [Abstract] [Full Text] [Related]

  • 3. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A, Varga V, Béres-Molnár KA, Vadasdi K, Bereczki D.
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [Abstract] [Full Text] [Related]

  • 4. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A, De Raedt S, Nieboer K, De Keyser J, Brouns R.
    Cerebrovasc Dis; 2010 Mar; 30(5):533-4. PubMed ID: 20881383
    [No Abstract] [Full Text] [Related]

  • 5. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE, Calle Escobar ML, Romero Sevilla RM.
    Cerebrovasc Dis; 2011 Mar; 32(6):614-5. PubMed ID: 22133608
    [No Abstract] [Full Text] [Related]

  • 6. Dabigatran and thrombolysis: A therapeutic dilemma.
    Govindarajan R, Salgado E.
    Ann Neurol; 2012 Oct; 72(4):625; author reply 625-6. PubMed ID: 23109156
    [No Abstract] [Full Text] [Related]

  • 7. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
    Prabhakaran S, Rivolta J, Vieira JR, Rincon F, Stillman J, Marshall RS, Chong JY.
    Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
    [Abstract] [Full Text] [Related]

  • 8. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ.
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [Abstract] [Full Text] [Related]

  • 9. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
    Dempfle CE, Hennerici MG.
    Cerebrovasc Dis; 2011 Jan; 32(6):616-9. PubMed ID: 22133643
    [No Abstract] [Full Text] [Related]

  • 11. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M, Szkotak A, Witt A, Shuaib A, Butcher K.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [Abstract] [Full Text] [Related]

  • 12. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA, Starr JA.
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of acute ischemic apoplexy].
    Andersen G, Krieger DW, Iversen HK.
    Ugeskr Laeger; 2009 Mar 23; 171(13):1094. PubMed ID: 19321089
    [No Abstract] [Full Text] [Related]

  • 14. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW.
    Cerebrovasc Dis; 2011 Mar 23; 31(3):229. PubMed ID: 21178346
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R, Vinuela F.
    Expert Rev Cardiovasc Ther; 2009 Apr 23; 7(4):375-87. PubMed ID: 19379062
    [Abstract] [Full Text] [Related]

  • 16. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
    Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, Olson DM, Hernandez AF, Peterson ED, Schwamm LH.
    Circulation; 2011 Feb 22; 123(7):750-8. PubMed ID: 21311083
    [Abstract] [Full Text] [Related]

  • 17. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC, Marrone AC.
    Cerebrovasc Dis; 2012 Feb 22; 34(3):246-7. PubMed ID: 23018342
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
    Duh PD, Leuckx PS, Warnez PM.
    J Pharm Belg; 2012 Mar 22; (1):37-8. PubMed ID: 22536682
    [No Abstract] [Full Text] [Related]

  • 19. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG.
    Pharmacotherapy; 2011 Apr 22; 31(4):335-7. PubMed ID: 21449622
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of cardioembolic stroke].
    Gil Núñez A.
    Neurologia; 2012 Mar 22; 27 Suppl 1():15-26. PubMed ID: 22682206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.